Cord Tissue

Your baby’s cord blood tissue, or umbilical cord lining, holds different stem cells, specifically Mesenchymal and Epithelial stem cells. Researchers are breaking new ground with these cells, with applications which could prove to be beneficial in the future for the treatment of many common diseases and afflictions, such as burns, diabetic wound care, heart disease, and a host of other indications. Treatments utilizing these cells are being referred to as the “Treatment of the Future” for their possible use treating conditions relating to muscle, cartilage and nerve cell regeneration. When banking both your baby’s cord blood and cord tissue stem cells, you increase your child’s chances of finding cures or treatments for both current and future, unforeseen diseases and conditions.

CariCord is the exclusive licensee CellResearch Corporation (“CRC”), which has developed proprietary and patented technology for harvesting and storing of umbilical cord lining tissue. Only CRC’s licensed partners are able to provide parents who wish to store their baby’s cord lining tissue with the assurance that their tissue can be used for therapies when needed. All cord lining tissue banked with CariCord will be included in the Global Cord Registry, and only tissue registered therein will be legally available for therapies.

The cord lining is the outermost layer of the umbilical cord that forms the connection between a baby and its mother. After a child is born, the umbilical cord is typically discarded as medical waste. However, scientists have discovered that the umbilical cord is in fact very rich in stem cells. The cord blood contains hematopoietic stem cells as well as mesenchymal stem cells; cord tissue contains mesenchymal stem cells in addition to epithelial stem cells.

The outstanding efficacy of stem cells used in wound healing has spurred CellResearch Corporation to accelerate development in this area, and beginning in 2016 CRC is collaborating with ClinImmune Labs with a clinical trial to seek FDA approval for use of these special stem cells for wound care treatment in the United States.